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Diagnostic performance of texture analysis on MRI in grading cerebral gliomas 
 
ABSTRACT 
 
BACKGROUND AND PURPOSE 
Grading of cerebral gliomas is important both in treatment decision and assessment 
of prognosis. The purpose of this study was to determine the diagnostic accuracy of 
grading cerebral gliomas by assessing the tumor heterogeneity using MRI texture 
analysis (MRTA).  
 
MATERIAL AND METHODS 
95 patients with gliomas were included, 27 low grade gliomas (LGG) all grade II and 
68 high grade gliomas (HGG) (grade III = 34 and grade IV = 34). Preoperative MRI 
examinations were performed using a 3T scanner and MRTA was done on 
preoperative contrast-enhanced three-dimensional isotropic spoiled gradient echo 
images in a representative ROI. The MRTA was assessed using a commercially 
available research software program (TexRAD) that applies a filtration-histogram 
technique for characterizing tumor heterogeneity. Filtration step selectively filters and 
extracts texture features at different anatomical scales varying from 2mm(fine 
features) to 6mm(coarse features), the statistical parameter standard deviation (SD) 
was obtained. Receiver operating characteristics (ROC) was performed to assess 
sensitivity and specificity for differentiating between the different grades and 
calculating a threshold value to quantify the heterogeneity. 
 
RESULTS 
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LGG and HGG was best discriminated using SD at fine texture scale, with a 
sensitivity and specificity of 93% and 81% (AUC 0.910, p<0.0001). The diagnostic 
ability for MRTA to differentiate between the different sub-groups (grade II - IV) was 
slightly lower but still significant.  
 
CONCLUSIONS 
Measuring heterogeneity in gliomas to discriminate HGG from LGG and between 
different histological sub-types on already obtained images using MRTA can be a 
useful tool to augment the diagnostic accuracy in grading cerebral gliomas and 
potentially hasten treatment decision.  
 
 
 
Abbreviations 
SD   standard deviation  
TA   texture analysis  
MRTA  MR texture analysis  
HGG   high grade gliomas  
LGG   low grade gliomas  
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Introduction 
  
Cerebral gliomas are the most common primary malignant brain tumour in adults and 
include astrocytoma, oligodendroglioma, mixed oliogoastrocytoma, and 
ependymoma (1). For prognostic and treatment purposes they are further stratified 
into two groups, high grade gliomas (HGG), classified as WHO grade III-IV tumours, 
and low grade gliomas (LGG), classified as WHO grade I-II tumours (2). HGG have 
in most cases a very low life expectancy (3, 4), while LGG is associated with a longer 
life expectancy (5, 6). Treatment for HGG normally includes surgical resection 
followed by radiotherapy with or without chemotherapy, while treatment for LGG  is 
usually surgical resection followed by close observation (7, 8). Hence, correct 
histological diagnosis is imperative for correct treatment. Brain biopsy represents the 
gold standard for histopathological diagnosis, which is based on nuclear 
pleomorphism, mitotic activity, cellularity, endothelial cell proliferation and presence 
of necrosis (9). This is increasingly challenged by new non-invasive advanced MRI 
techniques and research into additional sequences to improve radiological diagnostic 
accuracy. Image heterogeneity quantification could potentially lead to an objective 
and more accurate non-invasive radiological diagnosis which would impact patient 
management by allowing a more tailored and personalized management. Finding 
innovative ways to utilize pre-existing images has the potential to not only increase 
the  accuracy of  diagnoses but also optimally utilize scarce healthcare resources.  
Texture analysis (TA) assesses the distribution of gray-levels within an image to 
obtain texture features of intra-lesional heterogeneity (10, 11). Assessment of tumour 
heterogeneity, which is a well-recognized feature of malignancy, is important as it is 
related to poor prognosis (12). Imaging tumour heterogeneity via TA could be a non-
invasive tool to assess prognosis, disease-severity and treatment-response 
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evaluation and prediction (10, 11). A considerable amount of work has been done on 
CT texture analysis (CTTA) in the area of risk-stratification (13-16) compared to MRI. 
Due to its multi-parametric approach, MRI is visually more heterogeneous than CT 
and may be a powerful platform to quantify tumour heterogeneity with TA.  
The purpose of this study was two-fold: firstly to exploit the use of TA on contrast-
enhanced T1-weighted MR imaging to differentiate between HGG and LGG, and 
secondly to define the role of TA in the clinical decision-making process, in terms of 
sensitivity, specificity, and accuracy.  
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Material and methods 
 
Patients 
 
The regional ethics committee was consulted and informed consent was waived as 
this is a single institution retrospective study on archived anonymised data on 
patients with cerebral gliomas.  
Preoperative MRI studies of 95 patients with histopathological evidence of cerebral 
glioma between December 2006 and September 2012 were evaluated 
retrospectively.  
Samples were obtained by tumour resection or biopsy, and histopathological 
diagnosis determined according to the World Health Organization (WHO) 
classification of Tumours of the Central Nervous System (2). A total of 27 patients 
(mean age, 44 years; age range, 21 to 70 years) had histologically verified grade II, 
34 patients (mean age, 56 years; age range, 24 to 81 years) had histologically 
verified grade III and 34 patients (mean age, 58 years; age range, 25 to 87 years) 
had grade IV (glioblastoma multiforme). Detailed information is given in Table 1.   
 
MR Imaging 
 
All patients were examined with the same imaging acquisition protocol on a 3 T 
whole-body MRI system (Signa HDx, GE Medical Systems, Milwaukee, Wisconsin). 
The MRI protocol consisted of a T1 inversion recovery (T1 IR) sequence with the 
following parameters: TR / TE/ TI 2500 ms/9.6 ms/920 ms, FOV 240x240 mm, matrix 
size 384x224, slice thickness 5 mm, slice gap 1.5 mm. The T2-weighted sequence 
was performed with TR/TE 6000 ms/95 ms, FOV 240x240 mm, matrix size 480x480, 
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slice thickness 5 mm, slice gap 1 mm. The fluid-attenuated inversion-recovery 
(FLAIR) sequence was performed with TR/TE/TI 9500 ms/120 ms/2250 ms, FOV 
240x240 mm, matrix size 384x224, slice thickness 5 mm, slice gap 1.5 mm. After 
contrast medium gadopentate dimeglumine (Magnevist, Bayer Schering Pharma, 
Berlin, Germany), a three-dimensional isotropic spoiled gradient echo (SPGR) 
sequence, using the following parameters: TR/TE 7.8 ms/3 ms, FOV 256x256 mm, 
matrix size 256x256 mm, slice thickness 1 mm was acquired. 
 
Texture Analysis (TA) 
 
Post-contrast SPGR sequence was retrieved from the brain tumour preoperative 
protocol. The contrast-enhanced SPGR image with the largest axial cross-section of 
the tumour was selected for TA and the corresponding slice in DICOM (Digital 
Imaging and Communications in Medicine) format was retrieved. The TA was 
performed by a clinical researcher with 4 years experience with TA on radiographic 
imaging. The ROI was placed around the area of the tumour with the largets 
diameter of solid tumor, including both contrast enhanced tissue (or the solid portion 
of the tumour in cases of non-enhancing tumours) and necrosis, but avoiding large 
cysts, haemorrhages and oedema. The ROIs were drawn by the same researcher 
with guidance of a board-certified neuroradiologist, without knowledge of the final 
histological tumour diagnosis. The window level was manually set by the researcher 
to best display the tumour. This has no impact on the texture analysis results (i.e 
changing the window does not change the outcome of the generated texture 
parameters) just the visual perception. The MR texture analysis (MRTA) results were 
compared to histopathological diagnosis.  
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The MRTA methodology used for this study follows a previously published study on 
CTTA in gliomas (16), which employed a filtration-histogram technique. It extracts 
and enhances texture features at different sizes within the largest cross-section of 
the glioma on contrast enhanced SPGR image followed by histogram quantification. 
MRTA was carried out using a commercially available research software called 
TexRAD (TexRAD – www.texrad.com, part of Feedback Plc, Cambridge, UK) (13). 
The initial filtration step employs a Laplacian of Gaussian (LoG) band-pass filtration, 
which extracts and highlights image features at different sizes corresponding to 
spatial scale filter (SSF) ranging from 2-6 mm in width (radius) where SSF 2 mm = 
fine, SSF 3-5 mm= medium and SSF 6 mm = coarse texture features. SSF values 
lower than 2 were not considered, as they tend to represent image noise. 
Quantification of histogram (with and without filtration) was based on the parameter 
standard deviation (SD), which represents the width of the histogram or degree of 
variation from the mean pixel value (equation shown below).  
 
 
Were R is the ROI within the image a(x, y), n is the total number of pixels in R and ā 
is the mean value within R. 
A recent study by Miles et al (14) demonstrated that SD increases approximately in 
proportion to the square root of the number of objects (a component of image 
heterogeneity) highlighted by the filter and their mean intensity difference compared 
to background tissue (i.e. dark and bright objects are both positive). In other words a 
higher SD-value, implies increased tumor heterogeneity. (Figure 1) 
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Statistical Analysis 
 
The parameter SD was used to measure texture analysis with and without filtration 
which was correlated against grade II-IV using non-parametric Spearman rank 
correlation. To individually discriminate LGG from HGG, grade II from grade III, and 
grade III from grade IV, a two-tailed Mann Whitney test was applied.  
The areas under the curve (AUC) for SD to distinguish defined tumour grades were 
calculated by receiver operating characteristic (ROC) curve analysis. The optimal 
thresholds and their determined sensitivity and specificity were reported. Postitive 
predictive value (PPV) and negative predictive value (NPV) was also calculated from 
the ROC analysis. All statistical significance was set to 5% and was performed on 
SPSS (22.0.0.1) and MedCalc (MedCalc software, Mariakerke, Belgium). 
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Results 
 
Correlation analysis 
 
The correlation between the defined tumour grades and HGG vs LGG for SD was 
significant and is displayed in Table 2. Unfiltered SD with rs = 0.685 (p<0.0001) 
showed the best correlation between all the grades and SD filter value 2 displayed rs 
= 0.640 (p<0.0001) for HGG vs LGG correlation. 
 
Differences in MRTA values in glioma grading 
 
Table 3 summarizes all pair wise comparisons among the tumour grades. SD 
significantly differentiate between HGG and LGG, between grade II and grade III and 
grade III and grade IV gliomas for all the filters.  
 
Diagnostic performance of MRTA 
 
Tables 4 summarizes the ROC analysis results for SD, used to distinguish HGG from 
LGG (a), grade II from grade III gliomas (b) and grade III from grade IV (c). In the 
ROC curve analysis, the AUC for SD at SSF 2 best differentiated HGG from LGG 
(AUC = 0.910, p <0.0001, sensitivity = 80.9% specificity = 92.6% for a threshold 
above 1127, Table 4a, and ROC curve displayed in Figure 2). This filter revealed a 
PPV of 96.5% and NPV value of 65.8%. Likewise SD at SSF 2 was the best 
parameter for differentiating grade II from grade III (AUC = 0.837, p <0.0001, 
sensitivity = 70.6% specificity = 85.2%, Table 4b). Furthermore, SD without filtration 
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best differentiated grade III from grade IV (AUC = 0.728, p <0.001, sensitivity = 97% 
specificity = 44.1, Table 4c).  
A scatterplot of SD values at SSF 2 against glioma grade (Grade II, III, IV) for each 
individual case is shown in Figure 3. 
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Discussion 
 
 
Gliomas are heterogeneous lesions and histopathology is the gold standard for 
diagnosis, but has its limitations due to the inherently invasive procedure, sampling 
errors and variability in interpretation, especially in association with biopsy (9, 
17).This is one of the reasons why physiologic MRI techniques are playing an 
increasing role in grading gliomas and guiding neurosurgical management of brain 
tumours (18). Recent studies have demonstrated the value of metabolic and 
physiologic MR imaging techniques, such as DWI (19), DTI (20, 21), MRS (22, 23), 
DSC MRI (17, 24, 25),  and DCE MRI in the assessment of grading gliomas (26, 27). 
In addition, assessing the heterogeneity within a tumour by imaging might be of 
clinical benefit, particularly with the increased emphasis on personalized medicine. 
Hence, tumour heterogeneity is a clinically relevant parameter for imaging that may 
be quantifiable and could augment standard reporting methods (10). This study 
demonstrates the potential for MRTA to distinguish between LGG and HGG by 
quantifying heterogeneity, without additional imaging. TA is an easy post-processing 
step that can be performed on existing DICOM format images. 
The preliminary assessment of the diagnostic performance for MRTA yielded a 
sensitivity of 81% and specificity of 93% for differentiating HGG from LGG using the 
primary histogram parameter SD post filtration (fine-texture scale) at a threshold of 
1127. Patients with a SD value above 1127 indicate a high probability of HGG. For 
the same filter and parameter discussed above there is a significant correlation with 
tumour grade (rs = 0.640, p < 0.0001).  
These results can in part be explained by the correlation between tumour 
heterogeneity and tumour grade (4). The heterogeneity of gliomas is most likely 
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related to intra-tumoural spatial variation, angiogenesis, extravascular/extracellular 
matrix, and areas of necrosis (10). 
It is worth noting that other authors have selected different texture analysis 
parameters, such as entropy derived from ADC maps (28), or combining imaging 
features from several sequences and using support vector machines (29). A recent 
paper by Ryu et al (28) using TA on ADC maps found an AUC with entropy of 0.839. 
Entropy has also been related to the heterogeneity of tumour using CTTA (13, 18-
20).  
The method we have used for quantifying heterogeneity on MRI differs from other 
studies in two ways. Firstly we have used image filtration, where image features of 6 
pixels or higher were highlighted (LoG filter is similar to a non-orthogonal wavelet – 
providing the flexibility to tune the filter value to extract and separately evaluate fine, 
medium and coarse texture features). This filtration step is important to remove 
image heterogeneity that is due to noice and highlight biological important 
heterogeneity. This proved to be critical in our study as the most significant 
correlations with grade were obtained from filtered texture parameters, in contrast to 
texture quantification of conventional images without filtration. Secondly, first order 
histogram statistical parameters which are directionally independent, such as 
standard-deviation (degree of variation from the mean pixel value, SD) were used. 
Previous MR texture studies in gliomas have employed second-order statistical 
parameters which are direction-oriented, i.e. statistical methods focusing on direction 
and length of pixels such as grey-level run length or co-occurrence matrices. These 
are in general more complex and more difficult to reproduce. Using both image 
filtration and an easily comprehendible directionally independent parameter 
strengthens this study compared to that mentioned above.   
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Quantifying heterogeneity to distinguish the different sub-grades was significant. 
Differentiating between grade II vs. grade III was more significant than between 
grade III and IV. However the discrimination between the two high grades was quite 
pronounced in a previous study with TA on CT with contrast, sensitivity 91% and 
specificity 90% for SD (16). In addition, Ryn et al (28), using the ADC textural 
analysis parameters for differentiation between grade III and IV gliomas, found a 
sensitivity, specificity and accuracy of 81.8 %, 90 % and 84.4 % respectively.  
Concluding from this, portrayed texture from necrosis is probably more applicable to 
extract from CT and ADC textural analysis than MRTA based on contrast-enhanced 
SPGR, as this is the major factor that distinguishes grade III from grade IV. Thus, 
using TA as a multimodal approach (combining CTTA and MRTA) or as a 
multiparametric approach (combining ADC and contrast-enhanced SPGR) to brain 
tumour analysis can provide a more complete tumour heterogeneity profile than any 
one modality alone for the diagnosis and grading of gliomas. 
This is a novel technique to quantify these features in the different grades of gliomas. 
Previous studies using different acquisition techniques have been published. Many of 
these techniques are time consuming and can be difficult to reproduce. Our 
technique is user-friendly and uses an existing MRI sequence which is already part of 
the routine preoperative protocol. This is a single institution study and a large-scale 
clinical validation is needed. Biopsy will remain the gold standard, however, as brain 
biopsy is invasive and associated with sampling error, this study could be employed 
as an adjunct in confident decision-making, as part of the imaging contribution to the 
multidisciplinary approach to diagnosing patients with gliomas. Further emphasis 
should be placed on optimizing the potential of pre-existing radiological images. This 
should include exploring differences between the glioma sub-grades, as the 
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management of patients with gliomas differs not only between high grade and low 
grade tumours, but also between sub-grades. Recently the question has been raised 
of how non-histological data such as molecular information can be incorporated into 
the next WHO classification of CNS tumours (30). In agreement with Louis et al (30), 
we believe that the inclusion of non-tissue based information, i.e. clinical radiological 
information, can improve the clinical diagnostic work-up and biopsy guidance. 
Meaning the radiologist, in addition to reporting a preliminary diagnosis, can assist 
the neurosurgeons in getting a representative sample from the tumours area of 
highest heterogeneity, indicating the highest grade of the tumour and hence ensuring 
a representative tissue sample. This can make neuroimaging a more powerful 
noninvasive technique and have a positive impact on the care of patients with brain 
tumours. 
 
It should be noted that the use of the same acquisition protocol in all our 
examinations strengthens our study. It is well known that texture features are 
affected by the MR imaging acquisition, especially the gain-factor and spatial 
resolution (29). However, a few limitations were encountered: firstly, as a pilot study 
using the single largest axial cross-section MRI slice of the tumour, might not 
correspond to the specific site where the diagnostic biopsy was retrieved, poses as 
weighted limitations of this study; however, acquiring stereotactic biopsies before 
tumour resection is logistically difficult and not normally performed in patients with 
newly diagnosed gliomas.  In addition, a volumetric TA approach could show a more 
optimal representation of the tumour heterogeneity. Secondly, although the 
population comprises of consecutively selected patients meeting the inclusion 
criteria, there is a larger proportion of HGG compared to LGG, which has the 
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potential to skew the results. We attempted to mitigate this by using the first 34 of the 
total 142 patients with GBM. Thirdly, this was a retrospective study and therefore a 
prospective study using the thresholds highlighted in this study is needed to validate 
these results. 
  
 
Conclusions 
 
Quantifying glioma heterogeneity by using filtration and first order histogram 
statistical parameters such as SD determined by texture analysis highlights the 
different heterogeneous appearance of LGG and HGG as well as between glioma 
subgroups on contrast-enhanced SPGR images. This additional diagnostically useful 
information provided by texture analysis can augment the radiologists accuracy when 
grading gliomas. 
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Table 1. Showing inclusion and exclusion of patients. 
 
Table 2. Spearman Rank Correlation coefficients with P values, the best rs values 
and their p value is in bold. 
 
Table 3. Mann Whitney p values for SD SSF 2 to differentiate between HGG and 
LGG and sub-grades. 
 
Tabel 4.ROC analysis of SD differentiating A) HGG vs LGG, B) grade II vs grade III 
and C) grade III vs grade IV. The best AUC values are highlighted in bold. 
 
Figure 1. a) Contrast-enhanced SPGR image shows an intraaxial enhancing necrotic 
tumour (histopathologically verified as glioblastoma multiforme). The corresponding 
images selectively display, b) fine, c) medium and d) coarse textures.  
 
Figure 2. Graph shows receiver operating characteristic (ROC) curve of SD SSF 2 for 
differentiation of HGG from LGG. 
 
Figure 3. Scatterplot of SD SSF 2 for differentiating LGG from HGG, showing all 
individual cases in glial tumour grades II, III and IV. 
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